Welcome to Santa Cruz Biotechnology!

ALK-1 Antibodies

Santa Cruz Biotechnology, Inc. offers a broad range of ALK-1 antibodies. Select ALK-1 antibodies from several monoclonal and/or polyclonal ALK-1 antibodies listed below. View detailed ALK-1 antibody specifications by linking to the specific product blocks. Select appropriate ALK-1 antibodies for your research by isotype, epitope, applications and species reactivity. ALK-1 gene silencer products in siRNA, shRNA Plasmid and shRNA Lentiviral Particle formats are also available.

Introducing HOVERcruz™,

a unique system for rapid identification of ALK-1 Antibodies. Hover over product names in the table to see representative data for each product.

Live chat is now available! (click here)

Our live chat system is available to answer your product and ordering questions.

PRODUCT NAMECAT. #ISOTYPEEPITOPEAPPLICATIONSSPECIESCITATIONSRATING
ALK-1 (H-150)sc-28976rabbit IgGN-terminal (h)WB, IP, IF, ELISAm, r, h, e, c, p4
ALK-1 (C-20)sc-19547goat IgGC-terminus (h)WB, IP, IF, IHC(P), ELISAm, r, h, e, c, b, p1
ALK-1 (D-20)sc-19546goat IgGinternal (m)WB, IF, ELISAm, r, h, e7
ALK-1 (MM0015-8G33)sc-101555mouse IgG2extracellular (h)WBhuman
ALK-1 (RM0015-1B03)sc-101556rat IgG2extracellular (m)WB, IP, IFmouse and human

ALK-1 siRNA, shRNA Plasmid and shRNA Lentiviral Particles gene silencers include:

siRNAsshRNA PlasmidsshRNA Lentiviral ParticlesCITATIONSRANKING
ALK-1 siRNA (h): sc-40212ALK-1 shRNA Plasmid (h):
sc-40212-SH
ALK-1 shRNA (h)
Lentiviral Particles: sc-40212-V
ALK-1 siRNA (m): sc-40213ALK-1 shRNA Plasmid (m):
sc-40213-SH
ALK-1 shRNA (m)
Lentiviral Particles: sc-40213-V

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by vascular abnormalities such as dilated vessels, hemorrhages, liver and lung congestion, and brain or heart ischemia. Mutations in two genes, Endoglin (also designated CD105) and ALK-1 (activin receptor-like kinase 1, also designated TGFβ Superfamily RI), are responsible for HHT. Endoglin is mutated in HHT1, and ALK-1 is mutated in HHT2, both of which are thought to be caused by haploinsufficiency. Endoglin and ALK-1 are type III and type I members of the TGFβ receptor superfamily, respectively, that are expressed on vascular endothelial cells. Endoglin can only bind ligands of the TGFβ superfamily via association with the respective ligand binding receptors for TGFβ1, TGFβ3, Activin-A, BMP-2 and BMP-7. The human ALK-1 gene encodes two protein species which exist as a result of either glycosylation or alternative splicing events. ALK-1 preferentially binds TGFβ1 and is expressed in bone marrow stromal cells, lung, brain, kidney and spleen.